272 related articles for article (PubMed ID: 18540332)
1. [PETN: long acting nitrate with tolerance devoiding properties and innovative potential].
Richartz BM; Schneider HT; Silber S
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():43-7. PubMed ID: 18540332
[No Abstract] [Full Text] [Related]
2. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
Münzel T
MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
[No Abstract] [Full Text] [Related]
3. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
[No Abstract] [Full Text] [Related]
4. [Classic nitrate PETN (pentaerythritol tetranitrate). Initial data in pulmonary hypertension: no tolerance].
MMW Fortschr Med; 2002 Nov; 144(45):50. PubMed ID: 12534063
[No Abstract] [Full Text] [Related]
5. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
Kośmicki MA; Malczewska B; Sadowski Z
Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212
[TBL] [Abstract][Full Text] [Related]
7. [Pentaerythritol tetranitrate].
Friedrich EB; Böhm M
Dtsch Med Wochenschr; 2006 Apr; 131(14):749-50. PubMed ID: 16596492
[No Abstract] [Full Text] [Related]
8. Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.
Gori T; Daiber A
Am J Cardiovasc Drugs; 2009; 9(1):7-15. PubMed ID: 19178128
[TBL] [Abstract][Full Text] [Related]
9. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
[TBL] [Abstract][Full Text] [Related]
10. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Savonitto S; Motolese M; Agabiti-Rosei E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
[TBL] [Abstract][Full Text] [Related]
12. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
Schneider CA
Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
[No Abstract] [Full Text] [Related]
13. [The effect of five different long-acting nitroglycerine derivatives on angina pectoris].
Kaltenbach M; Tiedemann I; Schellhorn W
Dtsch Med Wochenschr; 1972 Oct; 97(40):1479-84. PubMed ID: 4627249
[No Abstract] [Full Text] [Related]
14. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
15. [Actions of pentaerithritol tetranitrate, isosorbide mononitrate and placebo on headache and ability to work of healthy subjects].
Pfaffenrath V; de la Motte S; Harrison F; Rüthning C
Arzneimittelforschung; 1998 Jun; 48(6):646-50. PubMed ID: 9689421
[TBL] [Abstract][Full Text] [Related]
16. [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
Kośmicki M; Kowalik I; Jedrzejczyk B; Sadowski Z
Pol Arch Med Wewn; 2002 Jun; 107(6):509-17. PubMed ID: 12371383
[TBL] [Abstract][Full Text] [Related]
17. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
18. Nitrate therapy for stable angina pectoris.
Parker JD; Parker JO
N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
[No Abstract] [Full Text] [Related]
19. Long-term use of short- and long-acting nitrates in stable angina pectoris.
Kosmicki MA
Curr Clin Pharmacol; 2009 May; 4(2):132-41. PubMed ID: 19442078
[TBL] [Abstract][Full Text] [Related]
20. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
